| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.77 | 0.003 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.003 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.22 | 0.004 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |